Skip to NavigationSkip to content

News

0
The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as a treatment for...
0
This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue Pharma and a Chicago...
0
Roche subsidiary Genentech has announced plans to axe 223 employees from its headquarters in San Francisco, California, beginning on 31 August and...
0
The Chinese government has fired a senior provincial official and is probing a former senior drug regulator in response to the Changsheng...

Features

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get her advice on replicating the...